Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (233)

« Back to Publications

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy

Altaf M. et al, (2026)

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial

Fumagalli MJ. et al, (2025)

Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals

Mellors J. et al, (2025), Nature Communications, 16

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies

Gunst JD. et al, (2025), Nature Communications, 16

MHC-related protein 1–restricted recognition of cancer via a semi-invariant TCR-α chain

Dolton G. et al, (2025), Journal of Clinical Investigation, 135

Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning

Igiraneza AB. et al, (2024), PLOS Computational Biology, 20, e1012618 - e1012618

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

Nel C. and Frater J., (2024), Frontiers in Immunology, 15

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection

Sun W. et al, (2024), Journal of Experimental Medicine, 221

Impact of antiretroviral therapy during primary HIV infection on T‐cell immunity after treatment interruption

Tipoe T. et al, (2024), European Journal of Immunology, 54

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies

Gunst J. et al, (2024)

Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery

Ali M. et al, (2024), Clinical and Experimental Immunology, 218, 78 - 92

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

Alagaratnam J. et al, (2024), Journal of Virus Eradication, 10, 100381 - 100381

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery

Thornhill JP. et al, (2024), AIDS, 38, 679 - 688

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population

Zacharopoulou P. et al, (2024), Frontiers in Immunology, 15

Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents

Sampson OL. et al, (2024), Frontiers in Immunology, 15

Load More

1
2
3
4
5
6
7
...
»